Optimal endoscopic resection method based on vertical margin distance for small rectal neuroendocrine tumors: Propensity score-matched study
- PMID: 40860711
- PMCID: PMC12371650
- DOI: 10.1055/a-2655-1320
Optimal endoscopic resection method based on vertical margin distance for small rectal neuroendocrine tumors: Propensity score-matched study
Abstract
Background and study aims: Advanced endoscopic resection methods are recommended for removing rectal neuroendocrine tumors (NETs) < 10 mm, but there is no consensus on optimal endoscopic technique. This study aimed to determine whether endoscopic mucosal resection with ligation (EMR-L) is superior to endoscopic submucosal dissection (ESD) in terms of efficacy and safety, focusing on achieving adequate vertical margin distance.
Patients and methods: This dual-center cohort study included consecutive patients with rectal NETs ≤ 10 mm. Adequate vertical margins were exploratively defined as a margin distance exceeding 115 μm, the 25th percentile threshold. Propensity score matching (PSM) was applied to compare outcomes between EMR-L and ESD.
Results: The study included 204 rectal NETs from 186 patients, with 61 lesions in each group after PSM. Compared with ESD, the EMR-L group demonstrated a higher R0 resection rate (98.4% vs. 83.6%, P = 0.021), a greater proportion of adequate vertical margins (80.3% vs. 62.3%, P = 0.030), and a lower rate of positive vertical margins (1.6% vs. 13.1%, P = 0.041). Subgroup analysis indicated that lesions ≤ 5 mm without prior biopsy or central depression derived greater benefit from EMR-L. Furthermore, EMR-L was associated with significantly shorter procedure times (median 5.0 vs. 19 minutes) and a markedly lower overall complication rate (8.2% vs. 29.5%, P = 0.005), particularly perforation (3.3% vs. 16.4%, P = 0.028).
Conclusions: EMR-L outperforms ESD for small rectal NETs by achieving higher R0 and better vertical margins in shorter times, while minimizing risk of perforation.
Keywords: CRC screening; Endoscopic resection (polypectomy, ESD, EMRc, ...); Endoscopy Lower GI Tract; Polyps / adenomas / ....
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
Conflict of Interest The authors declare that they have no conflict of interest.
Figures



Similar articles
-
Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis.J Gastrointest Surg. 2024 Mar;28(3):301-308. doi: 10.1016/j.gassur.2023.12.016. Epub 2024 Jan 23. J Gastrointest Surg. 2024. PMID: 38445925
-
Efficacy of endoscopic intermuscular dissection vs. endoscopic submucosal dissection in treating rectal neuroendocrine tumors < 10 mm.Endosc Int Open. 2025 Aug 6;13:a26415725. doi: 10.1055/a-2641-5725. eCollection 2025. Endosc Int Open. 2025. PMID: 40860702 Free PMC article.
-
Endoscopic treatment of rectal neuroendocrine tumors: a consecutive analysis of multi-institutional data.Ann Coloproctol. 2025 Jun;41(3):221-231. doi: 10.3393/ac.2024.00927.0132. Epub 2025 Jun 30. Ann Coloproctol. 2025. PMID: 40598988 Free PMC article.
-
Endoscopic resection therapies for rectal neuroendocrine tumors: a systematic review and meta-analysis.J Gastroenterol Hepatol. 2014 Feb;29(2):259-68. doi: 10.1111/jgh.12395. J Gastroenterol Hepatol. 2014. PMID: 24118068
-
Efficacy of endoscopic mucosal resection versus endoscopic submucosal dissection for rectal neuroendocrine tumors ≤10mm: a systematic review and meta-analysis.Ann Saudi Med. 2023 May-Jun;43(3):179-195. doi: 10.5144/0256-4947.2023.179. Epub 2023 Jun 1. Ann Saudi Med. 2023. PMID: 37270677 Free PMC article.
References
-
- Sekiguchi M, Hotta K, Takeuchi Y et al. Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY. J Gastroenterol. 2022;57:547–558. - PubMed
-
- Ngamruengphong S, Kamal A, Akshintala V et al. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors. Gastrointest Endosc. 2019;89:602–606. - PubMed
-
- Ramage JK, De Herder WW, Delle Fave G et al. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms. Neuroendocrinology. 2016;103:139–143. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous